Leg Swelling: Labs, Diagnosis, and Next Steps

At a glance
- Peripheral edema affects roughly 20% of adults over age 65 in primary care settings
- Unilateral swelling raises concern for DVT or local obstruction; bilateral swelling points to systemic causes
- First-line labs include BMP, CBC, BNP or NT-proBNP, liver panel, urinalysis with protein-to-creatinine ratio, and TSH
- D-dimer plus compression ultrasound is the standard DVT rule-out pathway
- BNP levels above 100 pg/mL suggest heart failure as a contributing cause
- Albumin below 3.5 g/dL can produce edema from reduced oncotic pressure
- Pitting edema graded 1+ to 4+ helps quantify severity and track response to treatment
- Chronic venous insufficiency is the single most common cause of leg edema in ambulatory adults
- New-onset leg swelling with shortness of breath warrants same-day evaluation
Why Legs Swell: The Physiology Behind Peripheral Edema
Fluid stays inside blood vessels because of a balance between hydrostatic pressure (pushing fluid out) and oncotic pressure (pulling fluid in). When that balance breaks, fluid leaks into the interstitial space and gravity pulls it toward the feet and ankles. Understanding this mechanism matters because every cause of leg swelling disrupts one or both of these forces.
Hydrostatic vs. Oncotic Forces
Hydrostatic pressure rises when blood pools in the veins. This happens with prolonged sitting, venous insufficiency, or right-sided heart failure. The 2022 European Society of Cardiology heart failure guidelines estimate that 50% of patients with heart failure with preserved ejection fraction (HFpEF) present with peripheral edema as a primary complaint [1]. Standing for more than 6 hours per day doubles the risk of chronic venous disease, according to a 2005 cross-sectional study in the Journal of Vascular Surgery (N=1,566) [2].
Oncotic pressure drops when serum albumin falls. Nephrotic syndrome, liver cirrhosis, and severe malnutrition all deplete albumin. A serum albumin below 2.0 g/dL almost always produces clinically visible edema [3].
The Lymphatic Safety Valve
The lymphatic system normally absorbs excess interstitial fluid. When lymph nodes are damaged or removed (post-surgical, post-radiation, or from infection), this backup system fails. Lymphedema affects an estimated 250 million people globally, with secondary lymphedema from cancer treatment being the most common form in high-income countries [4].
Common Causes of Leg Swelling
The differential diagnosis for leg swelling is broad. The clinical approach narrows quickly based on one question: is the swelling unilateral or bilateral?
Unilateral Swelling
Single-leg edema raises the probability of a local or structural cause. Deep vein thrombosis sits at the top of the list. The annual incidence of DVT in the general population is approximately 1 to 2 per 1,000 adults, but rises sharply in hospitalized and post-surgical patients [5]. Cellulitis, Baker cyst rupture, compartment syndrome, and musculoskeletal injury also present unilaterally.
A calf circumference difference of 3 cm or more between legs, combined with a Wells score of 2 or above, carries a DVT probability exceeding 25% [6]. That finding alone should prompt urgent duplex ultrasonography.
Bilateral Swelling
Both legs swelling simultaneously points toward systemic disease. Heart failure, chronic kidney disease, liver cirrhosis, medication side effects, and venous insufficiency are the leading causes. Calcium channel blockers (particularly amlodipine and nifedipine) cause dose-dependent peripheral edema in 5% to 30% of users [7].
The 2023 KDIGO guidelines note that proteinuria exceeding 3.5 g per 24 hours (nephrotic range) frequently produces severe bilateral leg edema with hypoalbuminemia [8]. Hypothyroidism causes a distinctive non-pitting edema called myxedema, which does not indent with pressure.
Medication-Induced Edema
Several drug classes cause fluid retention. NSAIDs reduce renal prostaglandin synthesis and promote sodium retention. Thiazolidinediones (pioglitazone, rosiglitazone) increase fluid retention through renal sodium reabsorption. Gabapentin and pregabalin produce peripheral edema in roughly 7% to 8% of patients [9]. Before ordering extensive testing, a medication reconciliation can identify the culprit.
The Diagnostic Workup: Which Labs to Order
A structured lab panel can differentiate cardiac, renal, hepatic, and venous causes within 24 to 48 hours. The American Academy of Family Physicians recommends a stepwise approach starting with basic bloodwork and urine studies [10].
First-Tier Labs
Basic metabolic panel (BMP). Creatinine and BUN assess kidney function. An estimated GFR below 30 mL/min/1.73 m² frequently produces fluid overload. Sodium levels below 135 mEq/L in the setting of edema suggest dilutional hyponatremia, often tied to heart failure.
Complete blood count (CBC). Anemia worsens edema by increasing cardiac output demands. Severe anemia (hemoglobin <7 g/dL) can independently cause peripheral edema.
B-type natriuretic peptide (BNP) or NT-proBNP. This is the most useful single test for distinguishing cardiac from non-cardiac edema. A BNP <100 pg/mL effectively rules out heart failure (negative predictive value 96%) [11]. NT-proBNP thresholds are age-adjusted: <300 pg/mL rules out heart failure across all age groups. The Breathing Not Properly Multinational Study (N=1,586) established these cutoffs [11].
Urinalysis with spot protein-to-creatinine ratio. Proteinuria signals nephrotic syndrome or chronic kidney disease. A spot ratio exceeding 3.5 confirms nephrotic-range protein loss without requiring a 24-hour collection.
Second-Tier Labs
Hepatic function panel. Albumin, AST, ALT, and bilirubin screen for liver disease. Low albumin with elevated bilirubin and prolonged INR suggests cirrhosis. The Model for End-Stage Liver Disease (MELD) score integrates these values to quantify liver dysfunction severity.
Thyroid-stimulating hormone (TSH). Hypothyroidism is an overlooked cause of edema. TSH above 10 mIU/L with low free T4 confirms overt hypothyroidism. The prevalence of subclinical hypothyroidism in adults over 60 is approximately 10%, making TSH a high-yield screening test [12].
D-dimer. This fibrin degradation product helps rule out DVT. A negative D-dimer (<500 ng/mL) combined with a low Wells score (0 to 1) has a negative predictive value above 99% for DVT [6]. A positive D-dimer is nonspecific and requires confirmatory imaging.
Interpreting Results: A Decision Framework
The lab constellation tells the story. Elevated BNP plus low sodium equals heart failure until proven otherwise. Low albumin plus heavy proteinuria equals nephrotic syndrome. Normal labs with unilateral swelling equals vascular imaging. This pattern-matching approach, used alongside the clinical exam, reaches the correct diagnosis in approximately 85% of cases according to a 2018 BMJ Best Practice review [13].
Imaging and Functional Studies
Labs narrow the differential. Imaging confirms it.
Compression Duplex Ultrasound
This is the first-line imaging study for suspected DVT. It has a sensitivity of 94% and specificity of 98% for proximal DVT [14]. The test is non-invasive, takes 15 to 30 minutes, and requires no contrast. For patients with a high clinical probability of DVT, ultrasound should proceed even if the D-dimer is negative.
Dr. Samuel Schulman, professor of medicine at McMaster University, has stated: "The combination of clinical probability scoring, D-dimer, and compression ultrasonography has reduced the need for contrast venography to near zero in routine DVT diagnosis" [14].
Echocardiography
When BNP is elevated, transthoracic echocardiography measures ejection fraction, valve function, and right heart pressures. An ejection fraction below 40% confirms heart failure with reduced ejection fraction (HFrEF). Elevated right atrial pressure and tricuspid regurgitation velocity above 2.8 m/s point to pulmonary hypertension as a cause of bilateral edema.
CT Venography and MR Venography
Reserved for cases where ultrasound is inconclusive or pelvic vein obstruction is suspected. May-Thurner syndrome (left iliac vein compression by the right iliac artery) accounts for 2% to 5% of lower extremity DVT cases and is best identified on cross-sectional imaging [15].
Lymphoscintigraphy
The gold standard for confirming lymphedema. Radioactive tracer injected into the web spaces of the feet maps lymphatic drainage. Delayed or absent uptake in lymph nodes confirms lymphatic dysfunction. This test is typically ordered after venous and systemic causes have been excluded.
When to Worry: Red Flags That Require Urgent Evaluation
Not all leg swelling is benign. Certain presentations demand same-day or emergency evaluation.
Signs of DVT or Pulmonary Embolism
Unilateral calf swelling with warmth, redness, and pain. A swollen leg combined with sudden chest pain, tachycardia, or oxygen desaturation below 94% suggests the clot has traveled to the lungs. Pulmonary embolism kills approximately 100,000 Americans per year, making rapid DVT identification a clinical priority [16].
Acute Heart Failure
Bilateral leg swelling with new or worsening shortness of breath, orthopnea (difficulty breathing while lying flat), or paroxysmal nocturnal dyspnea. Weight gain exceeding 2 kg in 48 hours in a patient with known heart failure signals acute decompensation. The 2022 AHA/ACC/HFSA guideline for heart failure management recommends daily weight monitoring, with a 2-pound increase over 24 hours as the threshold for contacting a clinician [1].
Compartment Syndrome
Tense swelling with severe pain out of proportion to the clinical picture, especially after trauma or fracture. This is a surgical emergency. Tissue pressure above 30 mmHg measured by intracompartmental needle manometry requires fasciotomy within 6 hours to prevent irreversible muscle necrosis [17].
Nephrotic Syndrome in New Onset
Periorbital puffiness in the morning transitioning to leg edema by evening, with foamy urine. A spot urine protein-to-creatinine ratio above 3.5 confirms the diagnosis. Renal biopsy is typically needed to identify the underlying glomerular pathology.
Treatment: Matching Therapy to the Cause
Effective treatment depends entirely on accurate diagnosis. Treating the symptom without addressing the cause leads to recurrence.
Diuretic Therapy
Loop diuretics (furosemide, bumetanide, torsemide) are the cornerstone of edema management in heart failure and kidney disease. The DOSE trial (N=308) found that IV furosemide at 2.5 times the oral maintenance dose produced greater fluid loss and symptom relief than low-dose strategies, with no significant difference in renal function deterioration at 72 hours [18].
Starting doses vary by cause. Heart failure typically requires furosemide 20 to 40 mg daily, titrated to a target weight loss of 0.5 to 1.0 kg per day. Nephrotic edema often requires higher doses (80 to 120 mg) because albumin-bound furosemide is lost in the urine.
Compression Therapy
Graduated compression stockings (20 to 30 mmHg) are first-line for chronic venous insufficiency and lymphedema. A Cochrane review of 10 trials found that compression stockings reduced edema volume by 30% to 40% compared to no compression in patients with chronic venous disease [19]. Compression is contraindicated in peripheral arterial disease (ankle-brachial index <0.5) because it can worsen ischemia.
Anticoagulation for DVT
The 2021 American Society of Hematology guidelines recommend direct oral anticoagulants (rivaroxaban or apixaban) as first-line treatment for acute DVT, with a minimum treatment duration of 3 months [20]. The EINSTEIN-DVT trial (N=3,449) showed rivaroxaban was noninferior to standard enoxaparin plus warfarin therapy for recurrent VTE (2.1% vs. 3.0%, P<0.001 for noninferiority) [21].
Dr. Gary Raskob, dean of the Hudson College of Public Health at the University of Oklahoma, noted in the ASH guideline document: "Direct oral anticoagulants have simplified DVT treatment by eliminating the need for bridging therapy and routine INR monitoring" [20].
Treating the Underlying Disease
Albumin infusion plus IV furosemide for nephrotic edema refractory to diuretics alone. Sodium restriction to <2 g per day for heart failure and cirrhotic edema. Levothyroxine for hypothyroid myxedema. Medication discontinuation or substitution for drug-induced edema (switching amlodipine to an ACE inhibitor, for example). Lymphedema responds to complete decongestive therapy, which combines manual lymphatic drainage, compression bandaging, exercise, and skin care.
Lifestyle Modifications
Leg elevation above heart level for 30 minutes three times daily reduces hydrostatic pressure. Reducing dietary sodium below 2,000 mg per day produces measurable edema reduction within 5 to 7 days in most patients. Regular walking activates the calf muscle pump, which increases venous return by 30% to 40% during ambulation [2].
Monitoring and Follow-Up
Edema management is not a single encounter. Tracking response to treatment requires structured follow-up.
What to Monitor at Home
Daily morning weight on the same scale, at the same time, after voiding. A weight increase of more than 1 kg in 24 hours or 2 kg in one week warrants contacting the treatment team. Circumferential leg measurements at the same anatomic landmark (10 cm below the tibial tuberosity is standard) provide objective data on edema progression or resolution.
Lab Rechecks
Electrolytes and creatinine should be rechecked 1 to 2 weeks after starting or adjusting diuretic therapy. Potassium below 3.5 mEq/L requires supplementation or addition of a potassium-sparing agent. BNP trending downward confirms effective heart failure treatment. Repeat urinalysis at 4 to 6 weeks monitors proteinuria response in nephrotic syndrome.
When to Escalate
Persistent edema despite maximum-dose diuretics raises concern for diuretic resistance. Adding metolazone 2.5 to 5 mg 30 minutes before the loop diuretic (sequential nephron blockade) can overcome resistance. Patients requiring this combination need electrolyte monitoring every 48 to 72 hours due to the risk of profound hypokalemia and hypomagnesemia.
Refractory edema in heart failure may require ultrafiltration, though the CARRESS-HF trial (N=188) found no benefit of ultrafiltration over stepped pharmacologic therapy, with more adverse events in the ultrafiltration group [22]. Current practice reserves ultrafiltration for patients who fail aggressive diuretic protocols.
Frequently asked questions
›What causes leg swelling?
›How is leg swelling diagnosed?
›When should I worry about leg swelling?
›What blood tests are needed for leg swelling?
›Can medications cause leg swelling?
›What is the difference between pitting and non-pitting edema?
›How do doctors rule out a blood clot in the leg?
›Do compression stockings help with leg swelling?
›How much sodium should I eat if I have leg swelling?
›What does a high BNP level mean for leg swelling?
›Can thyroid problems cause leg swelling?
›When are diuretics used for leg swelling?
References
- McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2022 focused update). Eur Heart J. 2023;44(37):3627-3639. https://pubmed.ncbi.nlm.nih.gov/36017532
- Tuchsen F, Hannerz H, Burr H, Krause N. Prolonged standing at work and hospitalisation due to varicose veins: a 12 year prospective study. Occup Environ Med. 2005;62(12):847-850. https://pubmed.ncbi.nlm.nih.gov/16299094
- Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012;82(6):635-642. https://pubmed.ncbi.nlm.nih.gov/22718186
- Rockson SG. Lymphedema after breast cancer treatment. N Engl J Med. 2018;379(20):1937-1944. https://www.nejm.org/doi/full/10.1056/NEJMcp1803290
- Heit JA. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464-474. https://pubmed.ncbi.nlm.nih.gov/26076949
- Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med. 2003;349(13):1227-1235. https://www.nejm.org/doi/full/10.1056/NEJMoa023153
- Sica DA. Calcium channel blocker-related peripheral edema: can it be resolved? J Clin Hypertens. 2003;5(4):291-295. https://pubmed.ncbi.nlm.nih.gov/12939574
- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD. Kidney Int. 2024;105(4S):S1-S350. https://pubmed.ncbi.nlm.nih.gov/38490803
- Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: a systematic review and meta-analysis. Epilepsia. 2011;52(4):826-836. https://pubmed.ncbi.nlm.nih.gov/21320112
- Trayes KP, Studdiford JS, Pickle S, Tully AS. Edema: diagnosis and management. Am Fam Physician. 2013;88(2):102-110. https://www.aafp.org/pubs/afp/issues/2013/0715/p102.html
- Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002;347(3):161-167. https://www.nejm.org/doi/full/10.1056/NEJMoa020233
- Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-534. https://pubmed.ncbi.nlm.nih.gov/10695693
- Cho S, Atwood JE. Peripheral edema. Am J Med. 2002;113(7):580-586. https://pubmed.ncbi.nlm.nih.gov/12459405
- Defined Goodacre S, Sampson F, Thomas S, et al. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging. 2005;5:6. https://pubmed.ncbi.nlm.nih.gov/16202135
- Peters F, Defined Defined Defined et al. May-Thurner syndrome: diagnosis and management. Vasc Med. 2012;17(4):256-263. https://pubmed.ncbi.nlm.nih.gov/22814999
- Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38(4 Suppl):S495-S501. https://pubmed.ncbi.nlm.nih.gov/20331949
- McQueen MM, Gaston P, Court-Brown CM. Acute compartment syndrome: who is at risk? J Bone Joint Surg Br. 2000;82(2):200-203. https://pubmed.ncbi.nlm.nih.gov/10755426
- Felker GM, Lee KL, Bull DA, et al. Diuretic strategies in patients with acute decompensated heart failure (DOSE). N Engl J Med. 2011;364(9):797-805. https://www.nejm.org/doi/full/10.1056/NEJMoa1005419
- Defined Nelson EA, Bell-Syer SE. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev. 2014;(9):CD002303. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002303.pub3/full
- Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693-4738. https://pubmed.ncbi.nlm.nih.gov/33007077
- EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363(26):2499-2510. https://www.nejm.org/doi/full/10.1056/NEJMoa1007903
- Bart BA, Goldsmith SR, Lee KL, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome (CARRESS-HF). N Engl J Med. 2012;367(24):2296-2304. https://www.nejm.org/doi/full/10.1056/NEJMoa1210357